-
Something wrong with this record ?
Anti-tumour necrosis factor treatment of severe psoriasis complicated by Epstein-Barr Virus hepatitis and subsequently by chronic hepatitis
P. Cetkovska, I. Lomicova, P. Mukensnabl, AC. Kroes,
Language English Country United States
Document type Case Reports, Journal Article
PubMed
26278774
DOI
10.1111/dth.12271
Knihovny.cz E-resources
- MeSH
- Antiviral Agents therapeutic use MeSH
- Biopsy MeSH
- Hepatitis, Chronic diagnosis drug therapy immunology virology MeSH
- Immunocompromised Host * MeSH
- Immunologic Factors adverse effects MeSH
- Remission Induction MeSH
- Epstein-Barr Virus Infections diagnosis drug therapy immunology virology MeSH
- Infliximab adverse effects MeSH
- Middle Aged MeSH
- Humans MeSH
- Opportunistic Infections diagnosis drug therapy immunology virology MeSH
- Alcohol Drinking adverse effects MeSH
- Psoriasis diagnosis drug therapy immunology MeSH
- Risk Factors MeSH
- Severity of Illness Index MeSH
- Tumor Necrosis Factor-alpha antagonists & inhibitors immunology MeSH
- Hepatitis, Viral, Human diagnosis drug therapy immunology virology MeSH
- Treatment Outcome MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Case Reports MeSH
A case is described of severe acute hepatitis in 47-year-old woman with chronic psoriasis and psoriatic arthritis treated with infliximab. Although clinical, serological and laboratory results were compatible with acute EBV hepatitis, it was difficult to differentiate between EBV infection and other non-infectious causes of hepatitis. The patient gradually developed chronic hepatitis with liver steatosis and efficient treatment with adalimumab had to be stopped. This case presents an uncommon complication that may arise from the use of biologic therapy and calls for caution in long-term management of psoriatic patients with internal comorbidities.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17001052
- 003
- CZ-PrNML
- 005
- 20180515104029.0
- 007
- ta
- 008
- 170103s2015 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/dth.12271 $2 doi
- 024 7_
- $a 10.1111/dth.12271 $2 doi
- 035 __
- $a (PubMed)26278774
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Cetkovska, Petra $u Department of Dermatology and Venereology, Medical Faculty and Teaching Hospital Pilsen, Charles University, Czech Republic.
- 245 10
- $a Anti-tumour necrosis factor treatment of severe psoriasis complicated by Epstein-Barr Virus hepatitis and subsequently by chronic hepatitis / $c P. Cetkovska, I. Lomicova, P. Mukensnabl, AC. Kroes,
- 520 9_
- $a A case is described of severe acute hepatitis in 47-year-old woman with chronic psoriasis and psoriatic arthritis treated with infliximab. Although clinical, serological and laboratory results were compatible with acute EBV hepatitis, it was difficult to differentiate between EBV infection and other non-infectious causes of hepatitis. The patient gradually developed chronic hepatitis with liver steatosis and efficient treatment with adalimumab had to be stopped. This case presents an uncommon complication that may arise from the use of biologic therapy and calls for caution in long-term management of psoriatic patients with internal comorbidities.
- 650 _2
- $a pití alkoholu $x škodlivé účinky $7 D000428
- 650 _2
- $a antivirové látky $x terapeutické užití $7 D000998
- 650 _2
- $a biopsie $7 D001706
- 650 _2
- $a infekce virem Epsteina-Barrové $x diagnóza $x farmakoterapie $x imunologie $x virologie $7 D020031
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a chronická hepatitida $x diagnóza $x farmakoterapie $x imunologie $x virologie $7 D006521
- 650 _2
- $a virová hepatitida u lidí $x diagnóza $x farmakoterapie $x imunologie $x virologie $7 D006525
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a imunokompromitovaný pacient $7 D016867
- 650 _2
- $a imunologické faktory $x škodlivé účinky $7 D007155
- 650 _2
- $a infliximab $x škodlivé účinky $7 D000069285
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a oportunní infekce $x diagnóza $x farmakoterapie $x imunologie $x virologie $7 D009894
- 650 _2
- $a psoriáza $x diagnóza $x farmakoterapie $x imunologie $7 D011565
- 650 _2
- $a indukce remise $7 D012074
- 650 _2
- $a rizikové faktory $7 D012307
- 650 _2
- $a stupeň závažnosti nemoci $7 D012720
- 650 _2
- $a výsledek terapie $7 D016896
- 650 _2
- $a TNF-alfa $x antagonisté a inhibitory $x imunologie $7 D014409
- 655 _2
- $a kazuistiky $7 D002363
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Lomicová, Iva, $d 1982- $u Department of Dermatology and Venereology, Medical Faculty and Teaching Hospital Pilsen, Charles University, Czech Republic. $7 xx0224258
- 700 1_
- $a Mukensnabl, Petr $u Department of Pathology, Medical Faculty and Teaching Hospital Pilsen, Charles University, Czech Republic.
- 700 1_
- $a Kroes, Aloysius C M $u Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands.
- 773 0_
- $w MED00005384 $t Dermatologic therapy $x 1529-8019 $g Roč. 28, č. 6 (2015), s. 369-72
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/26278774 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170103 $b ABA008
- 991 __
- $a 20180515104202 $b ABA008
- 999 __
- $a ok $b bmc $g 1180192 $s 961619
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 28 $c 6 $d 369-72 $e 20150817 $i 1529-8019 $m Dermatologic therapy $n Dermatol Ther $x MED00005384
- LZP __
- $a Pubmed-20170103
